BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC has launched a new lidocaine product line, starting with lidocaine 5% in ointment form. The company also expects to launch a transdermal ...

The global lidocaine ointment market is expected to exhibit a CAGR of 7.7% during the forecast period. Due to the increasing approval of new drug for lidocaine ointment formulation. For instance, in ...

Lidocaine 5%; water miscible. Sepsis. Traumatized mucosa. Severe shock. Heart block. Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or ...

AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) announced today the signing of a definitive agreement under which Hi-Tech acquired rights to market generic Lidocaine 5% ...

SunGen Pharma, has received the Food and Drug Administration’s approval for lidocaine ointment, in a dosage strength of 5%. It is used for production of anesthesia of accessible mucous membranes of ...

* Company's Estonian Unit, Teligent OÜ, has received approval from Health Canada's therapeutic products directorate for lidocaine ointment USP 5 percent Source text for Eikon: Further company coverage ...

Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity ...

The approval given by the US Food & Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc USA (Glenmark) is for Lidocaine Ointment USP, 5 per cent, the company said in a statement. The approval ...

Maximum Strength Bacitraycin Plus Ointment with lidocaine was recalled Wednesday because the packaging is not child resistant, which is required by the Poison Prevention Packaging Act. The pain ...

Glenmark Pharmaceuticals today announced receipt of final approval from US health regulator for its generic version of AstraZeneca's Xylocaine ointment. The approval given by the US Food & Drug ...